Ashley Dunn
Board of Directors
Cancer
Look good feel better
New Zealand
Biography
Ashley Dunn (Chair) has been involved in cancer research since 1984, when he and colleagues isolated the first clone of GM-CSF, a cytokine which is today given clinically to aid recovery of bone marrow in cancer patients following chemotherapy treatment. In 1982 he joined the Ludwig Institute for Cancer Research in Melbourne, Australia where he headed the Molecular Biology Program. He was appointed the Institute’s Associate Director in 1992 and served until 2004. Professor Dunn has served on numerous national and international committees and scientific boards. He is an Honorary Professorial Fellow of the University of Melbourne, and has authored more than one hundred scientific publications. He was elected a Fellow of the Australian Academy of Science in 1996 and is currently an Honorary of the Department of Surgery at the University of Melbourne. Professor Dunn is now a science consultant and serves on a number of Boards and Advisory Boards within the biotechnology sector.
Research Interest
Cancer
